Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Cervical Cancer Metastatic × camrelizumab × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 3 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Locally Advanced Gastric Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Esophageal Neoplasms 1 Cervical Cancer Metastatic 1 Advanced Gastric Cancer 1 Advanced Colorectal Carcinoma 1

Interventions

famitinib 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07266350 2025-12-05

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

Chongqing University Cancer Hospital

Not yet recruiting

Cervical Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡